Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
45 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
A diagnosis in accordance with Criteria for the Diagnosis of Primary Osteoporosis.
Other inclusion criteria as specified in the study protocol.
Patients having secondary osteoporosis or another condition that presents low bone mass.
Patients having findings that affect measurement of lumbar spinal bone mineral density by DXA
Patients that have been administered bisphosphonate derivatives.
Other exclusion criteria as specified in the study protocol.